Acquisition History / Olympus Corporation / BioProtect
Olympus Corporation Acquires BioProtect
Announced May 26, 2026 — $270M
What happened
BioProtect is an Israeli maker of devices used in prostate cancer treatment. Japanese medtech group Olympus agreed to buy the company for US$270M in an all-cash deal.
- Acquirer
- Olympus Corporation
- Target
- BioProtect
- Announced
- May 26, 2026
- Price
- $270M
- Industry
- Medical devices (prostate cancer treatment)
- Buyer type
- Strategic acquirer
- Status
- Announced, not yet closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Olympus Corporation acquire BioProtect?
Olympus Corporation acquired BioProtect on May 26, 2026. This was Olympus Corporation's 1st publicly tracked acquisition out of 2 we have on record.
How much did Olympus Corporation pay for BioProtect?
Olympus Corporation paid $270M for BioProtect.
What does BioProtect do?
BioProtect is an Israeli maker of devices used in prostate cancer treatment. Japanese medtech group Olympus agreed to buy the company for US$270M in an all-cash deal.
What other Medical devices (prostate cancer treatment) companies has Olympus Corporation acquired?
BioProtect is Olympus Corporation's only publicly tracked acquisition in Medical devices (prostate cancer treatment) so far.
More Olympus Corporation acquisitions
BioProtect Ltd.
$270M · 2026